Strasbourg, 09/10/2001 (Agence Europe) - Adopting a resolution on two patent requests for human genes (BRC A1 and BRC A2) during its emergency debate, the European Parliament expressed its concern at the potential impact of the European Patent Office (EPO) awarding such a patent.
Since the beginning of 2001, the EPO has already granted two patents to the US company Myriad Genetics for the first of the above-mentioned human genes, and has given a favourable response to the new request for...